What is numares?
Numares Health AG, headquartered in Regensburg, Germany, operates as a key player in the in-vitro diagnostics sector. The company specializes in developing and providing a fully automated platform designed to streamline diagnostic processes. This technological advancement positions numares to address critical needs within healthcare, offering efficient and reliable diagnostic solutions.
How much funding has numares raised?
numares has raised a total of $21.3M across 1 funding round:
Debt
$21.3M
Debt (2022): $21.3M with participation from European Investment Bank
Key Investors in numares
European Investment Bank
The European Investment Bank (EIB), established in 1958, is the European Union's nonprofit long-term lending and finance institution, often supporting strategic infrastructure and innovation projects across the EU.
What's next for numares?
The substantial enterprise-level funding and recent strategic investment signal a strong growth trajectory for numares. This capital is expected to fuel further development of its automated in-vitro diagnostics platform, potentially expanding its market reach and enhancing its technological capabilities. The company appears poised for significant scaling, leveraging this financial backing to solidify its position in the competitive healthcare diagnostics market.
See full numares company page
